MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04310nam a22003737a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220511s20222022 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0741-5214 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1016/j.jvs.2022.03.869 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
S0741-5214(22)01363-5 [pii] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
35470015 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
In-situ Bypass Is Associated with Superior Infection-free Survival Compared to Extra-Anatomic Bypass for the Management of Secondary Aortic Graft Infections Without Enteric Involvement. |
| 251 ## - Source |
|---|
| Source |
Journal of Vascular Surgery. 2022 Apr 22 |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
J Vasc Surg. 2022 Apr 22 |
| 253 ## - Journal Name |
|---|
| Journal name |
Journal of vascular surgery |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Publication date |
2022 Apr 22 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2022-05-11 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
CONCLUSIONS: After complete resection of AGI, perioperative mortality is 16% and median overall survival is 5.8 years. EAB is associated with nearly a two-and-half fold higher re-infection/mortality compared to ISB. Omental and/or muscle flap coverage of the repair appear protective. Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
METHODS: A retrospective, multi-institutional study of AGI from 2002-2014 was performed using a standardized database. Baseline demographics, comorbidities, and perioperative variables were recorded. The primary outcome was infection-free survival. Descriptive statistics, Kaplan-Meier survival analysis, and univariate and multivariable analyses were performed. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
OBJECTIVE: The optimal revascularization modality following complete resection of aortic graft infection (AGI) without enteric involvement remains unclear. The purpose of this investigation is to determine the revascularization approach associated with the lowest morbidity and mortality using real-world data in patients undergoing complete excision of AGI. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
RESULTS: 241 patients at 34 institutions from 7 countries presented with AGI during the study period (median age 68 years; 75% male). The initial aortic procedures that resulted in AGI were 172 surgical grafts (71%) and 66 endografts (27%) and 3 unknown (2%). 172 (71%) of the patients underwent complete excision of infected aortic graft material followed by in situ (in-line) bypass (ISB), including antibiotic-treated prosthetic graft (35%), autogenous femoral vein (NAIS) (24%), and cryopreserved allograft (41%). 69 patients (29%) underwent extra-anatomic bypass (EAB). Overall median Kaplan-Meier (KM) estimated survival was 5.8 years. Perioperative mortality was 16%. When stratified by ISB versus EAB, there was a significant difference in KM estimated infection-free survival (2910 days, IQR 391, 3771 versus 180 days, IQR 27, 3750 days; p<0.001). There were otherwise no significant differences in presentation, comorbidities, nor perioperative variables. Multivariable Cox regression showed lower infection-free survival among patients with EAB (HR 2.4, 95% CI 1.6-3.6; p<0.001), polymicrobial infection (HR 2.2, 95% CI 1.4-3.5; p=0.001), MRSA infection (HR 1.7, 95% CI 1.1-2.7; p=0.02), as well as the protective effect of omental/muscle flap coverage (HR 0.59, 95% CI 0.37-0.92; p=0.02). |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Heart & Vascular Institute |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Coleman, Dawn M |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Davis, Frank M |
| 790 ## - Authors |
|---|
| All authors |
Aziz F, Back M, Baril DT, Bath J, Beck AW, Behrendt CA, Belkin M, Black JH 3rd, Bose S, Chiesa R, Cho S, Chung J, Coleman DM, Conrad MF, Coselli JS, Crofts S, Czerny M, D'Oria M, Davila VJ, Davis FM, DeMartino R, Elsayed R, Farber MA, Fatima J, Fujimura N, Gavali H, Go MR, Hacker RI, Hsu JH, Hubbard G, Humphries MD, Irshad A, Janko MR, Joh JH, Kahlberg A, Kashyap VS, Kreibich M, Lawrence PF, Lee JT, Lemmon GW, Lepidi S, Liang P, Liapis CD, Magee GA, McFarland GE, Motta F, Moulakakis KG, Obara H, Patel R, Pomozi E, Ricco JB, Rizzo AN, Schermerhorn M, Setacci C, Shah SK, Shalhub S, Shutze W, Sobreira ML, Stoecker JB, Szeberin Z, Wang GJ, Wang LJ, Wang SK, Wanhainen A, Wishy AM, Woo K, Yoshida WB, Zhang Q, Zhou W |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1016/j.jvs.2022.03.869">https://dx.doi.org/10.1016/j.jvs.2022.03.869</a> |
| Public note |
https://dx.doi.org/10.1016/j.jvs.2022.03.869 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
